Page last updated: 2024-08-23

nimustine and Neuroectodermal Tumors

nimustine has been researched along with Neuroectodermal Tumors in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kochi, M; Kuratsu, J; Mihara, Y; Seto, H; Takaki, S; Uemura, S; Ushio, Y	1

Other Studies

1 other study(ies) available for nimustine and Neuroectodermal Tumors

Article	Year
Ventriculolumbar perfusion of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosou rea hydrochloride. Neurosurgery, 1993, Volume: 33, Issue:5 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cerebellar Neoplasms; Chemotherapy, Cancer, Regional Perfusion; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Dose-Response Relationship, Drug; Ependymoma; Female; Follow-Up Studies; Glioblastoma; Half-Life; Humans; Injections, Intraventricular; Injections, Spinal; Male; Medulloblastoma; Meningeal Neoplasms; Metabolic Clearance Rate; Neoplasm Recurrence, Local; Neuroectodermal Tumors; Nimustine; Prohibitins; Subarachnoid Space; Survival Rate	1993

Article

Year

Ventriculolumbar perfusion of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosou rea hydrochloride.

Neurosurgery, 1993, Volume: 33, Issue:5

Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cerebellar Neoplasms; Chemotherapy, Cancer, Regional Perfusion; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Dose-Response Relationship, Drug; Ependymoma; Female; Follow-Up Studies; Glioblastoma; Half-Life; Humans; Injections, Intraventricular; Injections, Spinal; Male; Medulloblastoma; Meningeal Neoplasms; Metabolic Clearance Rate; Neoplasm Recurrence, Local; Neuroectodermal Tumors; Nimustine; Prohibitins; Subarachnoid Space; Survival Rate

1993